Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Respirology (Carlton, Vic.)|December 28, 1999
Characterization of immunoglobulin binding factor in sputum from patients with chronic airway diseasesW Ichikawa, F Ogushi, K Tani, et al.
British Journal of Cancer|March 30, 2006
Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancerM Inokuchi, T Yamashita, H Yamada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1991
[The changes in tumor marker levels after chemolipiodolization in early phase]W Ichikawa, Z Nihei, S Sawai, et al.
Mechanisms of Ageing and Development|October 15, 1993
Differential effect of host microenvironment and systemic humoral factors on the implantation and the growth rate of metastatic tumor in parabiotic mice constructed between young and old miceR Hirayama, K Takemura, Z Nihei, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 2, 1999
Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindredsS Iida, Y Akiyama, W Ichikawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 22, 2000
[Chemoradiotherapy with low-dose cisplatin and 5-FU for advanced esophageal cancer]M Tajima, W Ichikawa, Y Takagi, et al.
British Journal of Cancer|September 9, 2004
Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancerW Ichikawa, T Takahashi, K Suto, et al.
British Journal of Cancer|October 17, 2003
Both gene expression for orotate phosphoribosyltransferase and its ratio to dihydropyrimidine dehydrogenase influence outcome following fluoropyrimidine-based chemotherapy for metastatic colorectal cancerW Ichikawa, H Uetake, Y Shirota, et al.
Cancer|May 11, 2001
Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinomaR Ohno, K Yoshinaga, T Fujita, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1993
[Preoperative intra-arterial injection of mitoxantrone for locally advanced breast cancer]W Ichikawa, Z Nihei, T Yamashita, et al.
Pageof 5